# Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion

Study · id `cardio:ct-nct01887704` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01887704](<https://clinicaltrials.gov/study/NCT01887704>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01887704

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.

## Technical summary

Registry record NCT01887704. Randomized; single masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2013-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 240 participants (enrolled count; ClinicalTrials.gov record NCT01887704, source copy `cardio:ctgov-nct01887704-2013-06-27`, retrieved 2026-10-26)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT01887704, source copy `cardio:ctgov-nct01887704-2013-06-27`, retrieved 2026-10-26)
- Primary completion: 2013-05 (actual) (ClinicalTrials.gov record NCT01887704, source copy `cardio:ctgov-nct01887704-2013-06-27`, retrieved 2026-10-26)
- Completion: 2013-05 (actual) (ClinicalTrials.gov record NCT01887704, source copy `cardio:ctgov-nct01887704-2013-06-27`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01887704, source copy `cardio:ctgov-nct01887704-2013-06-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01887704-2013-06-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion
- Condition: Coronary Artery Disease
- Intervention (Device): Rotablator
- Intervention (Procedure): conventional angioplasty
- Intervention (Procedure): stenting
- Intervention (Device): Cutting balloon
- Intervention (Drug): Aspirin
- Intervention (Drug): Clopidogrel
- Intervention (Device): Paclitaxel-eluting stent
- Intervention (Device): zotarolimus-eluting stent
- Intervention (Device): Everolimus-eluting stent
- Intervention (Device): Sirolimus-eluting stent
- Lead sponsor: Capital Medical University
- Lead sponsor class: OTHER
- Collaborator: Beijing Anzhen Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry lists this organization as the lead sponsor: Capital Medical University (`cardio:org-capital-medical-university`)
- Registry lists this organization as a collaborator: Beijing Anzhen Hospital (`cardio:org-beijing-anzhen-hospital`)

## Provenance

Content hash: bc68908dc6ec9da524b2de152c830a7eea13aa0104037458e568f05d6077dc46
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
